CF
PLSE icon

Corebridge Financial’s Pulse Biosciences PLSE Stock Holding History

Corebridge Financial’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,970
Closed -$144K – 2049
2025
Q1 		$144K Sell
8,970
-132
-1% -$2.46K ﹤0.01% 2254
2024
Q4 		$158K Sell
9,102
-687
-7% -$12.1K ﹤0.01% 2306
2024
Q3 		$172K Sell
9,789
-61
-0.6% -$1.04K ﹤0.01% 2302
2024
Q2 		$110K Buy
+9,850
New +$92.8K ﹤0.01% 2543

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Corebridge Financial's PLSE Position: Q2 2025 in Review

Corebridge Financial sold out of Pulse Biosciences (PLSE) in Q2 2025, closing a stake of 8,970 shares — an estimated $144K sold.

Corebridge Financial first reported a position in PLSE in Q2 2024 and held it in 4 quarters. The position peaked at $172K in Q3 2024. 86 funds tracked by Wall St. Rank hold PLSE as of Q2 2025.

  • Corebridge Financial reported no remaining Pulse Biosciences position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 8,970 Pulse Biosciences shares in Q2 2025, an estimated $144K.
  • Corebridge Financial first reported a position in Pulse Biosciences in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Pulse Biosciences position peaked at $172K in Q3 2024.
  • 86 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.